@FierceBiotech: Sanofi, Regeneron capture a shot at first-mover advantage in the PCSK9 market. Report | Follow @FierceBiotech
@JohnCFierce: Rockwell's dialysis drug wins an FDA OK, despite lingering doubts. Article | Follow @JohnCFierce
@DamianFierce: Under-rated aspect of $GILD's hep C dominance: correctly spelling "hepatology." More | Follow @DamianFierce
> London-based NightStaRx has banked new venture cash and recruited J&J ($JNJ) veteran David Fellows as its new CEO. The company is developing new gene therapies, with a lead program for Choroideremia, a rare inherited cause of blindness that affects around 1 in 50,000 people. Release
> The Milan-based gene therapy biotech Genenta has raised 6 million euros for its R&D work. Story
> Syndax has pulled its $60 million IPO. Story
Medical Device News
@FierceMedDev: ICYMI: Profit down 12% at Intuitive Surgical, but procedure volume up due to strength abroad and in general surgery. Report | Follow @FierceMedDev
@VarunSaxena2: GE Healthcare says strong U.S. growth offset weakness abroad. Story | Follow @VarunSaxena2
@EmilyWFierce: Obama and Narendra Modi scheduled to meet with top U.S. and Indian execs today to discuss business barriers. Story from the WSJ (sub. req.) | Follow @EmilyWFierce
> Study shows ventricular assist devices allow diseased hearts to regenerate muscle. Story
> Neurostim dry eye startup backed by Kleiner Perkins, NEA readies for CE mark. More
> FDA approves first glucose-monitoring app for mobile devices. Article
Pharma News
@FiercePharma: Harvard engineer taps immunotherapy for insights into nonsurgical pet sterilization. FierceAnimalHealth story | Follow @FiercePharma
@EricPFierce: Actavis explains the recall of generic Neurontin was limited to 2,000 bottles shipped to one customer. FiercePharmaManufacturing story | Follow @EricPFierce
> Novo Nordisk puts 500 Saxenda reps on U.S. streets, aiming for $1B in weight-loss sales. More
> Gilead discounts hep C meds in Germany, offers new-and-improved generics deal in India. News
Biotech IT News
> EMA posts guide to help IT teams with its new pharmacovigilance database. News
> Obama talks up precision meds, cybersecurity in SOTU speech. More
> $4B VC shop lays out its vision for the future of digital health. Story
> GoBalto eyes Asian expansion after $12M Mitsui-led financing. Report
> BIO is preparing small biotechs for life in the social media maelstrom. Article
CRO News
> Trial tech outfit goBalto bags $12M to expand around the world. Report
> PPD beefs up its Irish outpost with a new biologics lab. News
> Australian CRO Novotech firms up its Hong Kong presence. More
> EMA wants more than 700 drugs suspended over GVK data scandal. Story
> Covance pools its early-stage R&D services into one offering. Article
Animal Health News
> Report: Merck said to be testing lower dosage Zilmax to revive sales. More
> Bayer study reveals growth opportunity for vet clinics in fighting parasites. Item
> Valeant CEO quashes rumors of Zoetis buyout bid. Article
> Harvard engineer taps immunotherapy for insights into nonsurgical pet sterilization. Story
> Report: Livestock research lab prioritizes profits over animal health. More